Logo
LogoHome Icon
 Clinics
Labs
Book a demo
For Labs
Grow test volume. Build long-term value from your diagnostic data.
Founding partner playbooks
Integrate once to make your tests orderable across the Pathway22.ai clinic network. Then, with appropriate permissions, contribute eligible de-identified results to a governed diagnostic-data biobank for approved research and AI opportunities
Book demo
60+ clinics registered interest in 24 hours  ·  Post-quantum encryption  ·  UK, UAE and US
One platform. The entire clinical lab stack
We run the clinic network. Your lab plugs into it.
We run the clinic network. Your lab plugs into it.
Pathway22.ai is the complete EHR and operating system for longevity and preventative-medicine clinics. Labs integrate once to access this growing clinical network—creating two advantages: increased test distribution and a governed longitudinal diagnostic-data resource.
15
Founding lab partnerships available
NO UPFRONT FEE
Upfront integration fee for founding partners
100
Clinics targeted in the first year
4
International lab partners signed
logo letters
One integration. Two growth opportunities for diagnostic labs.
One integration. Two growth opportunities for diagnostic labs.
Pathway22.ai is the complete EHR and clinical operating system used by longevity and preventative-medicine clinics—creating a connected distribution network for diagnostic and specialty labs.
Grow test volume across the network. Integrate once to make your tests discoverable, orderable and reportable across participating Pathway22.ai clinics, without creating a separate agreement, portal and interface for every clinic.Build long-term value from diagnostic data. With appropriate permissions, eligible results can be de-identified and structured into a governed longitudinal data resource for approved research and AI opportunities. Your lab retains governance and contractual control over its distribution.
FOUNDING LAB PROGRAM
The first 15 laboratory partners join with no upfront integration fee through an agreed revenue-share model.
The opportunity
Your diagnostic data is worth more than a single result.
Every test creates clinically valuable data, but after the result is delivered, much of that value remains unused. Pathway22.ai helps eligible diagnostic data become de-identified, structured and longitudinally useful for approved research and medical-AI applications.
A GROWING MARKET
Research organisations, life-science companies and medical-AI developers need high-quality diagnostic data that reflects real patients over time.
A GOVERNED BIOBANK
Consent, permissions, de-identification and access controls are built into the model. Participating labs retain governance and contractual control over approved use.
Distribution, rethought
Stop selling to clinics one at a time.
Integrate your test catalogue once and make it orderable within every participating clinic on Pathway22.ai.Orders are placed inside the patient record and results return directly to it without a separate sales agreement, portal or custom interface for every clinic.As the clinic network grows, your distribution grows with it.This is clearer than “Stop selling to clinics one at a time,” while retaining the same commercial promise.
FOUNDING NETWORK · 15 LAB PARTNERS · 100 CLINICS TARGETED
From clinic-by-clinic sales to network-wide distribution.
The old way
— lab by lab
A separate deal for every lab
A custom interface built per practice
Yet another portal for staff to learn
Growth is linear with your sales effort
The Pathway22.ai model
— one connected network
One integration, then orderable everywhere
Build once — the network does the distribution
Ordering lives in the tools clinicians already use
Reach compounds as clinics join
Pathway22.ai will work for you
Biomarker Labs
Diagnostic Labs
Specialty Labs
Genomics Labs
Metabolic Labs
One integration gives your lab access to a clinic network designed to scale.
Pathway22.ai is targeting 100 clinics in year one and 1,500 within five years. As participating clinics join, your tests can become available across the network without negotiating and building a separate integration for each clinic.
15X growth in five years — and your reach grows with the network, at no additional cost to you.
As the clinic network grows, your potential distribution grows with it.
SECOND GROWTH ENGINE · GOVERNED DATA ACCESs
Turn diagnostic data into a governed, recurring revenue stream
With appropriate permissions, eligible diagnostic data can be de-identified and made available for approved research and medical-AI use. Your lab retains governance and contractual control over access, permitted purposes and commercial terms.
Become a founding partner
->
Protect. Govern. Prove.
Pathway22.ai operates the platform. Participating labs retain governance and contractual control over their contributed data, including permitted uses, access conditions and commercial terms.
Protected
01
Eligible data is processed within controlled cloud infrastructure using encryption, role-based access and authenticated user accounts.
Access is restricted to authorised users and approved workflows.
De-identified
02
Before approved secondary use, eligible data undergoes defined de-identification and disclosure-risk controls appropriate to the intended purpose.
Direct patient identifiers are not made available to research or medical-AI users.
Governed & Auditable
03
Consent status, permitted purpose, data provenance, access and withdrawal are recorded to support traceability and oversight.
Every approved use is governed by permissions and contractual controls.
SECURITY, PRIVACY & GOVERNANCE
Protected by design. Governed at every step.
Pathway22.ai is designed to support regulated clinical-data workflows. Participating labs retain governance and contractual control over contributed data, permitted uses, access conditions and commercial terms.
Post-quantum-ready encryption
FHIR-ready
ISO 13485 in progress
Certified anonymisation
HIPAA-aligned
ISO 27001 & SOC 2 roadmap
GDPR-aligned
Privacy by design
Designed around GDPR data-protection principles and to support HIPAA-regulated workflows through access controls, auditability and configurable safeguards.
Controlled data environment
Patient information is processed within controlled cloud infrastructure, with access restricted by roles, permissions and authenticated accounts.
Certified anonymisation → De-identification controls
Data approved for secondary use undergoes documented de-identification and disclosure-risk controls before access is granted.
Consent-led & revocable
Nothing moves without recorded patient consent. Access is per-group, logged, time-limited — and you can switch it off at any time.
Future-proof encryption
Post-quantum-ready encryption designed to keep health data secure for the decades it must be kept.
Regional data hosting
Hosting options help laboratories meet applicable data-residency and localisation requirements, subject to the selected deployment region.
Full audit trail
A tamper-proof record of who consented, where data came from and who may use it — traceable for regulators and your compliance team.
Standards-based integration
FHIR-ready connections to your existing lab system — secure, standard links, with no rip-and-replace.
You keep ownership
Your raw data and the asset built from it stay yours. Using anonymised data to improve the platform never transfers ownership.
FOUNDING LAB PARTNER PROGRAM
15 founding lab partners. Two ways to grow.
No platform fee. No subscription. Pathway22.ai earns only when it generates revenue for your lab.
Join the founding cohort shaping how diagnostic tests reach clinicsand how permissioned diagnostic data can support approved research and medical-AI applications.
4/15 places taken
FOUNDING LAB COHORT
Founding partners pay no platform or subscription fee. Under agreed commercial terms, Pathway22.ai participates only in revenue generated through the platform: new test orders from the clinic network and approved secondary use of permissioned diagnostic data.
Meet the Founder
->
100
Clinics in year one
Test volume from a network scaling fast
No revenue share on diagnostic test sales. Pathway22.ai may earn revenue only through separately contracted, legally permitted services, such as approved research or medical-AI applications involving permissioned diagnostic data.
$
0
To join
Revenue share only on what we earn for you
4
/15
Founding places taken
Only a handful of founding places remain
Built by people who understand regulated healthcare.
Experience across clinical operations, diagnostics and health-data infrastructure informs how Pathway22.ai is designed,from integration and governance to auditability and secure data use.
FOUNDING LAB COHORT · 15 PLACES · 4 TAKEN
Be one of the first 15.
Founding cohort · 50 labs · 100 clinics
Be one of the first 15.
One integration creates two opportunities, new test volume across the Pathway22.ai clinic network and, where permitted, revenue from approved uses of de-identified diagnostic data. Your lab retains governance and contractual control throughout.
Meet the Founder
Waitlist
learn more
Frequently asked questions
What is Pathway22.ai?
+

Pathway22.ai is an early-stage health technology company focused on building what it describes as a medical intelligence infrastructure for longevity, precision, and preventive medicine. Rather than creating another consumer health app or electronic health record (EHR), the company aims to provide the underlying data and intelligence layer that connects clinics, laboratories, practitioners, and patients into a unified ecosystem.

What is medical intelligence infrastructure?
+

Pathway22.ai is an early-stage health technology company focused on building what it describes as a medical intelligence infrastructure for longevity, precision, and preventive medicine. Rather than creating another consumer health app or electronic health record (EHR), the company aims to provide the underlying data and intelligence layer that connects clinics, laboratories, practitioners, and patients into a unified ecosystem.

Who is Pathway22.ai built for?
+

Pathway22.ai is an early-stage health technology company focused on building what it describes as a medical intelligence infrastructure for longevity, precision, and preventive medicine. Rather than creating another consumer health app or electronic health record (EHR), the company aims to provide the underlying data and intelligence layer that connects clinics, laboratories, practitioners, and patients into a unified ecosystem.

What is tokenised clinical data exchange?
+

Pathway22.ai is an early-stage health technology company focused on building what it describes as a medical intelligence infrastructure for longevity, precision, and preventive medicine. Rather than creating another consumer health app or electronic health record (EHR), the company aims to provide the underlying data and intelligence layer that connects clinics, laboratories, practitioners, and patients into a unified ecosystem.

How is Pathway22.ai different from a traditional EHR?
+

Pathway22.ai is an early-stage health technology company focused on building what it describes as a medical intelligence infrastructure for longevity, precision, and preventive medicine. Rather than creating another consumer health app or electronic health record (EHR), the company aims to provide the underlying data and intelligence layer that connects clinics, laboratories, practitioners, and patients into a unified ecosystem.

Home
For Clinics
For Labs
© 2026 Pathway22.ai. All rights reserved.
The complete EHR for longevity and preventive medicine—connecting patient records, clinical workflows, diagnostics and a secure laboratory data marketplace in one platform.
Book a demo
->
Founder
->
logo letters